Search

everythinglearnresearchcommunity

for

Search:↓

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Taking oral testosterone with finasteride or dutasteride doubles testosterone levels, and food slightly affects it.

Large prostates link to more hair loss.

Current treatments for androgenetic alopecia are limited, but research is ongoing to find better solutions.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Chitosan-coated nanoparticles improve skin delivery of hair loss treatments with fewer side effects.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Both drugs lower DHT levels, with GI198745 being more effective.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Certain drugs that block specific enzymes can help treat prostate diseases.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.